Journal of Medicinal Chemistry p. 6734 - 6750 (2019)
Update date:2022-08-15
Topics:
Wang, Qinghui
Arnst, Kinsie E.
Wang, Yuxi
Kumar, Gyanendra
Ma, Dejian
White, Stephen W.
Miller, Duane D.
Li, Wei
Li, Weimin
ABI-231 is a potent, orally bioavailable tubulin inhibitor that interacts with the colchicine binding site and is currently undergoing clinical trials for prostate cancer. Guided by the crystal structure of ABI-231 in complex with tubulin, we performed structure-activity relationship studies around the 3-indole moiety that led to the discovery of several potent ABI-231 analogues, most notably 10ab and 10bb. The crystal structures of 10ab and 10bb in complex with tubulin confirmed their improved molecular interactions to the colchicine site. In vitro, biological studies showed that new ABI-231 analogues disrupt tubulin polymerization, promote microtubule fragmentation, and inhibit cancer cell migration. In vivo, analogue 10bb not only significantly inhibits primary tumor growth and decreases tumor metastasis in melanoma xenograft models but also shows a significant ability to overcome paclitaxel resistance in a taxane-resistant PC-3/TxR model. In addition, pharmacological screening suggested that 10bb has a low risk of potential off-target function.
View MoreYurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
Skyrun Industrial Co.,Ltd(expird)
website:http://www.chinaskyrun.com
Contact:0086-576-84610586
Address:Chemical Development Zone
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Jining tiansheng chemical co.,ltd.
Contact:+86-537-5158722
Address:ROOM 1011, BLOCK B, CUIDU INTERNATIOAL BUSINESS CENTER, JINING CITY, CHINA
HENAN NEW BLUE CHEMICAL CO.,LTD
website:http://www.newbluechem.com
Contact:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Doi:10.1021/jo970882t
(1997)Doi:10.1021/jo9711495
(1997)Doi:10.1016/S0020-1693(00)81368-7
(1986)Doi:10.1016/S0040-4039(97)01588-8
(1997)Doi:10.1021/jo001323g
(2001)Doi:10.1002/jhet.5570340418
(1997)